Therefore, the inclusion of additional patients with different renal diseases and CKD stages would increase statistical power and might help to unravel the role of TFF2 in the acute phase of renal failure and during progression to end-stage renal disease. This evidence concerns the gene TFF2 and Renal insufficiency.